There is good news for those with acute pain, as the FDA has approved a first-of-its-kind pain medication, and it’s one ...

Experiencing pain may increase the odds that cancer survivors will use cigarettes and cannabis, according to a recent study published by Wiley online in CANCER, a peer-reviewed journal of the American ...

Obtaining approval from the U.S. Food and Drug Administration (FDA) for a key medication can be a huge catalyst for a ...

It’s the first FDA approval for a pain medication in 25 years. How does the drug work, and who is it for?

This month the FDA has approved Journavx, a medication that mimics proteins that can help block pain signals from reaching ...

Journavx can be taken with ibuprofen for its anti-inflammatory effects. The prescription medication is not in pharmacies yet, but it maybe there by the end of February. Click here to report a typo.

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

Vertex sees 2025 revenue of $11.75 billion to $12.0 billion, the midpoint of which is above analysts' average expectation of ...

Greater pain intensity in cancer survivors correlates with increased cigarette, e-cigarette, and cannabis use, but decreased alcohol consumption. Greater pain intensity in cancer survivors has been ...

Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...

In a recent study, majority non-White communities had at least 40 percent lower mean adjusted per-capita distribution than majority White communities.

Experiencing pain may increase the odds that cancer survivors will use cigarettes and cannabis, according to a recent study published by Wiley online in CANCER.